Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes, 24-7 Posted: Wednesday, December 12, 2012

You don’t get days off from diabetes. It has to be managed constantly, and not just by monitoring your blood sugar and taking medication appropriately

Diabetes Drugs May Reduce Risk for Affective Disorders Posted: Monday, December 10, 2012

Sulfonylureas and metformin may help to reduce the risk for depression.

New Insulin Pump PaQ® Enabling Glycemic Control without Daily Insulin Injections for People with Type 2 Diabetes Approved in Europe Posted: Monday, December 03, 2012

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ® Insulin Delivery Device has received CE Mark approval.

New Treatment Reduces Weight 10 Percent and Improves Insulin Sensitivity Posted: Sunday, December 02, 2012

A new, lab-created antibody that mimics the action of a naturally occurring molecule causes weight loss.

Diabetes Drug Can Restore Memory Loss from Alzheimer's Posted: Saturday, November 24, 2012

A drug that was initially used to treat insulin resistance in diabetes patients has shown promise as a way to improve cognitive function in Alzheimer's sufferers.

Regular Glucose Monitoring Increases Medication Adherence and Reduces A1c Posted: Sunday, October 28, 2012

Blood glucose monitoring at least once a day is associated with reduced A1C levels and greater adherence to medication in type 2 diabetes patients who do not take insulin.

EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points Posted: Tuesday, October 09, 2012

A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.

EASD: Once a Year Exenatide Introduced at EASD Posted: Monday, October 08, 2012

Continuous long-term delivery of exenatide with Intarcia's osmotic mini-pump system allows optimal dose selection for improved glycemic control, ensures adherence, and improves patient tolerability.

EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes Posted: Monday, October 08, 2012

Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

L-cysteine a Possible Therapy for Type-2 Diabetes Posted: Tuesday, October 02, 2012

Taking L-cysteine supplements may help patients with type 2 diabetes better control blood sugar levels.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.